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Dr. Hausenloy and colleagues reply: Landoni 
et al. and Wagner et al. suggest that the use of 
propofol or opioids, respectively, may have con-
tributed to the failure of RIPC to improve clinical 
outcomes after cardiac surgery. Although we can-
not rule out this possibility, the current data are 
not conclusive. The evidence that RIPC may be 
less effective with the use of propofol is limited 
to two small clinical studies.1,2 In several experi-
mental studies, propofol itself has been reported 
to confer cardioprotection; one of these studies 
used a clinically relevant porcine model of car-
diopulmonary bypass surgery.3 Furthermore, there 
is no clear relationship between propofol use and 
the cardioprotective efficacy of RIPC. Several 
clinical studies show RIPC cardioprotection de-
spite the presence of propofol, and others show 
no benefit with RIPC, even without the use of 
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propofol. Similarly, there is no obvious relation-
ship between opioid use and cardioprotection 
conferred by RIPC. Many clinical studies show 
cardioprotective effects of RIPC with the use of 
opioids administered at the time of induction of 
anesthesia, maintenance of anesthesia, or both.
Other factors that may have affected the car-
dioprotective efficacy of RIPC in cardiac surgery 
should also be considered. RIPC protects against 
acute myocardial ischemia–reperfusion injury, 
but in cardiac surgery the causes of myocardial 
injury are multifactorial and include direct han-
dling of the heart, coronary microembolization, 
and inflammation. RIPC may be less effective in 
patients who undergo coronary-artery bypass 
grafting with concomitant valve surgery. Coex-
isting conditions such as older age, diabetes, and 
hypertension may attenuate cardioprotection as-
sociated with RIPC. Data are lacking on the 
most appropriate number and duration of cycles 
of RIPC. Finally, the use of other medications 
such as beta-blockers, statins, antianginal agents 
such as nicorandil, and nitrates during cardiac 
surgery may also interfere with the cardioprotec-
tive effects of RIPC.
The ERICCA and RIPHeart studies did not 
show improved clinical outcomes with RIPC af-
ter cardiac surgery. However, RIPC still may have 
therapeutic potential in patients with acute myo-
cardial infarction, in whom the magnitude of 
myocardial injury is more substantial than the 
injury that occurs during cardiac surgery.
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